Related Experiment Video
Updated: Jul 20, 2026

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
Published on: June 4, 2021
Catheter-directed thrombolysis with percutaneous rheolytic thrombectomy versus thrombolysis alone in upper and lower
Hyun S Kim1, Ajanta Patra, Ben E Paxton
1Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. sikhkim@jhmi.edu
Insights
Catheter-directed thrombolysis (CDT) with rheolytic percutaneous mechanical thrombectomy (PMT) is as effective as CDT alone for deep vein thrombosis (DVT). This combined approach significantly reduces treatment time and urokinase dosage for acute proximal extremity DVT.
Area of Science:
- Vascular Surgery
- Interventional Radiology
- Thrombosis Management
Background:
- Deep vein thrombosis (DVT) of the extremities poses significant risks.
- Catheter-directed thrombolysis (CDT) is a treatment option for extensive DVT.
- Percutaneous mechanical thrombectomy (PMT) offers an adjunct to thrombolysis.
Purpose of the Study:
- To compare the efficacy of CDT alone versus CDT combined with rheolytic PMT.
- To evaluate outcomes for upper and lower extremity deep vein thrombosis (DVT).
Main Methods:
- Retrospective cohort study of patients with acute iliofemoral or brachiosubclavian DVT.
- Comparison of urokinase CDT alone versus combined CDT and rheolytic PMT.
- Analysis of treatment duration, lytic dose, clot lysis rates, and complications.
Main Results:
- Combined CDT and rheolytic PMT group had significantly shorter treatment duration (26.3 hr vs. 48.0 hr).
- Combined group required lower mean urokinase doses (2.7 million units vs. 5.6 million units).
- Complete clot lysis rates were comparable: 82% for combined therapy vs. 73% for CDT alone.
Conclusions:
- CDT with rheolytic PMT is effective for acute proximal extremity DVT.
- Pharmacomechanical thrombolysis offers reduced treatment time and lytic agent requirement.
- Further randomized trials are recommended to confirm these benefits.
Purpose:
To compare the efficacy of catheter-directed thrombolysis (CDT) alone versus CDT with rheolytic percutaneous mechanical thrombectomy (PMT) for upper and lower extremity deep vein thrombosis (DVT).
Methods:
A retrospective cohort of consecutive patients with acute iliofemoral or brachiosubclavian DVT treated with urokinase CDT was identified, and a chart review was conducted. Demographic characteristics, treatment duration, total lytic dose, clot lysis rates and complications were compared in patients treated with urokinase CDT alone or combined CDT and rheolytic PMT.
Results:
Forty limbs in 36 patients were treated with urokinase CDT alone. Twenty-seven limbs in 21 patients were treated with urokinase CDT and rheolytic PMT. The mean treatment duration for urokinase CDT alone was 48.0 +/- 27.1 hr compared with 26.3 +/- 16.6 hr for urokinase CDT and rheolytic PMT (p = 0.0004). The mean urokinase dose required for CDT alone was 5.6 +/- 5.3 million units compared with 2.7 +/- 1.8 million units for urokinase CDT with rheolytic PMT (p = 0.008). Complete clot lysis was achieved in 73% (29/40) of DVT treated with urokinase CDT alone compared with 82% (22/27) treated with urokinase CDT with rheolytic PMT.
Conclusion:
Percutaneous CDT with rheolytic PMT is as effective as CDT alone for acute proximal extremity DVT but requires significantly shorter treatment duration and lower lytic doses. Randomized studies to confirm the benefits of pharmacomechanical thrombolysis in the treatment of acute proximal extremity DVT are warranted.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism III: Nursing Management
